CXCR4 involvement in neurodegenerative diseases-Reference-Cited by-同舟云学术

CXCR4 involvement in neurodegenerative diseases

Published:2018-04-11 Issue:1 Volume:8 Page:
ISSN:2158-3188
Container-title:Translational Psychiatry
language:en
Short-container-title:Transl Psychiatry

Author:

Bonham Luke W., ,Karch Celeste M.^ORCID,Fan Chun C.^ORCID,Tan Chin^ORCID,Geier Ethan G.,Wang Yunpeng^ORCID,Wen Natalie,Broce Iris J.,Li Yi,Barkovich Matthew J.^ORCID,Ferrari Raffaele,Hardy John,Momeni Parastoo,Höglinger Günter^ORCID,Müller Ulrich,Hess Christopher P.,Sugrue Leo P.,Dillon William P.,Schellenberg Gerard D.,Miller Bruce L.,Andreassen Ole A.^ORCID,Dale Anders M.,Barkovich A. James,Yokoyama Jennifer S.,Desikan Rahul S., ,

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Cellular and Molecular Neuroscience,Psychiatry and Mental health

Link

http://www.nature.com/articles/s41398-017-0049-7.pdf

Reference61 articles.

1. Dickson, D. W., Rademakers, R. & Hutton, M. L. Progressive supranuclear palsy: pathology and genetics. Brain. Pathol. 17, 74–82 (2007).

2. Kovacs, G. G. Invited review: Neuropathology of tauopathies: Principles and practice. Neuropathol. Appl. Neurobiol. 41, 3–23 (2015).

3. Boxer, A. L. et al New diagnostics and therapeutics for progressive supranuclear palsy. Lancet Neurol. 16, 552–563, https://doi.org/10.1016/S1474-4422(17)30157-6 (2017).

4. Bang, J., Spina, S. & Miller, B. L. Frontotemporal dementia. Lancet 386, 1672–1682 (2015).

5. Dubois, B. et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6, 734–746 (2007).

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice;Brain, Behavior, and Immunity;2024-10

2. Inhibition of CXCR4: A perspective on miracle fruit seed for Alzheimer's disease treatment;Experimental Neurology;2024-09

3. Neuroinflammation Parallels 18F‐PI‐2620 Positron Emission Tomography Patterns in Primary 4‐Repeat Tauopathies;Movement Disorders;2024-07-18

4. IL-1β and CXCR4 as Potential Therapeutic Targets for Alzheimer’s Disease;Combinatorial Chemistry & High Throughput Screening;2024-05-20

5. Epigenetic Mechanism of SETD1B-mediated Histone Methylation in Cognitive Impairment Induced by Sevoflurane Anesthesia in Neonatal Mice;Neuroscience;2024-05